393 related articles for article (PubMed ID: 16651809)
21. A novel mechanism of neuroprotection: Blood glutamate grabber.
Castillo J; Loza MI; Mirelman D; Brea J; Blanco M; Sobrino T; Campos F
J Cereb Blood Flow Metab; 2016 Feb; 36(2):292-301. PubMed ID: 26661174
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha.
Cimarosti H; Jones NM; O'Shea RD; Pow DV; Salbego C; Beart PM
Neurosci Lett; 2005 Sep; 385(1):52-7. PubMed ID: 15927375
[TBL] [Abstract][Full Text] [Related]
23. Estrogens as neuroprotectants against ischemic stroke.
Alonso de Leciñana M; Egido JA
Cerebrovasc Dis; 2006; 21 Suppl 2():48-53. PubMed ID: 16651814
[TBL] [Abstract][Full Text] [Related]
24. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke.
Mallolas J; Hurtado O; Castellanos M; Blanco M; Sobrino T; Serena J; Vivancos J; Castillo J; Lizasoain I; Moro MA; Dávalos A
J Exp Med; 2006 Mar; 203(3):711-7. PubMed ID: 16520390
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
Chen WF; Sung CS; Jean YH; Su TM; Wang HC; Ho JT; Huang SY; Lin CS; Wen ZH
Neuroscience; 2010 Feb; 165(4):1217-32. PubMed ID: 19932886
[TBL] [Abstract][Full Text] [Related]
26. Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom.
Fontana AC; de Oliveira Beleboni R; Wojewodzic MW; Ferreira Dos Santos W; Coutinho-Netto J; Grutle NJ; Watts SD; Danbolt NC; Amara SG
Mol Pharmacol; 2007 Nov; 72(5):1228-37. PubMed ID: 17646426
[TBL] [Abstract][Full Text] [Related]
27. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia.
Calabresi P; Cupini LM; Centonze D; Pisani F; Bernardi G
Ann Neurol; 2003 Jun; 53(6):693-702. PubMed ID: 12783414
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke.
Hurtado O; De Cristóbal J; Sánchez V; Lizasoain I; Cárdenas A; Pereira MP; Colado MI; Leza JC; Lorenzo P; Moro MA
FASEB J; 2003 Nov; 17(14):2082-4. PubMed ID: 14500556
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of action of neuroprotectants in stroke.
Lyden P; Wahlgren NG
J Stroke Cerebrovasc Dis; 2000 Nov; 9(6 Pt 2):9-14. PubMed ID: 17895214
[TBL] [Abstract][Full Text] [Related]
30. Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: an in vitro study of maslinic acid.
Qian Y; Guan T; Tang X; Huang L; Huang M; Li Y; Sun H; Yu R; Zhang F
Eur J Pharmacol; 2011 Jan; 651(1-3):59-65. PubMed ID: 21118675
[TBL] [Abstract][Full Text] [Related]
31. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
32. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells.
Zschocke J; Allritz C; Engele J; Rein T
Glia; 2007 May; 55(7):663-74. PubMed ID: 17311293
[TBL] [Abstract][Full Text] [Related]
34. [Neuroprotection in brain ischemia--doubts and hopes].
Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism.
Zhao LD; Wang JH; Jin GR; Zhao Y; Zhang HJ
J Ethnopharmacol; 2012 Mar; 140(2):339-44. PubMed ID: 22306289
[TBL] [Abstract][Full Text] [Related]
36. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
Xiong ZG; Zhu XM; Chu XP; Minami M; Hey J; Wei WL; MacDonald JF; Wemmie JA; Price MP; Welsh MJ; Simon RP
Cell; 2004 Sep; 118(6):687-98. PubMed ID: 15369669
[TBL] [Abstract][Full Text] [Related]
38. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
[TBL] [Abstract][Full Text] [Related]
39. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
40. [Current situation of neuroprotection in stroke].
Martínez-Vila E; Irimia-Sieira P; Gállego-Culleré J
Rev Neurol; 1999 Sep 16-30; 29(6):526-36. PubMed ID: 10584268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
